You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 213072


✉ Email this page to a colleague

« Back to Dashboard


NDA 213072 describes ROSZET, which is a drug marketed by Althera Pharms and is included in one NDA. There are two patents protecting this drug. Additional details are available on the ROSZET profile page.

The generic ingredient in ROSZET is ezetimibe; rosuvastatin calcium. There are twenty-four drug master file entries for this compound. Additional details are available on the ezetimibe; rosuvastatin calcium profile page.
Summary for 213072
Tradename:ROSZET
Applicant:Althera Pharms
Ingredient:ezetimibe; rosuvastatin calcium
Patents:2
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 213072
Generic Entry Date for 213072*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;EQ 5MG BASE
Approval Date:Mar 23, 2021TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:May 1, 2033Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF HYPERLIPIDEMIA
Patent:⤷  Sign UpPatent Expiration:May 1, 2033Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF HYPERLIPIDEMIA

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;EQ 10MG BASE
Approval Date:Mar 23, 2021TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:May 1, 2033Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF HYPERLIPIDEMIA

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.